Efficacy of Addiction Pharmacotherapy in Alcohol Use Disorder and Their Effects on Liver Health  

作　　者：Jiahua Zhou Jiajing Li Qiuwei Pan brahim Ayada 

机构地区：[1]Department of Gastroenterology and Hepatology,Erasmus MC-University Medical Center,Rotterdam,the Netherlands

出　　处：《Journal of Clinical and Translational Hepatology》2024年第8期750-754,共5页临床与转化肝病杂志（英文版）

摘　　要：Both alcohol-associated liver disease(ALD)and metabolic dysfunction-associated steatotic liver disease are leading contributors to chronic liver diseases.These conditions often coexist,exacerbating disease progression.Despite ALD being a leading cause of liver transplantation,many individuals with alcohol use disorder(AUD)do not receive treatment.In this review,we discussed the epidemiology of ALD in AUD,various treatment options for AUD,and their efficacy on liver health.Our critical analysis of current evidence underscores the need for integrated models involving multiple stakeholders to improve ALD management.

关 键 词：Alcohol use disorder Alcohol-associated liver disease Addiction pharmacotherapy Under treatment Metabolic dysfunctions Liver health Multidisciplinary clinics 

分 类 号：R575[医药卫生—消化系统]